Andrew J. Gentles

Andrew J. Gentles's indexed work centers on computational deconvolution of tumor immune composition, most prominently the prognostic landscape of genes and infiltrating immune cells across human cancers, a first-author study that remains his most-cited at over 3,000 citations. Earlier first-author work extended this computational thread to leukemic stem cell gene expression signatures associated with clinical outcomes in acute myeloid leukemia, while his senior-author role on amino acid runs in eukaryotic proteomes and their disease associations reflects an enduring interest in sequence-level genomics informing disease. Beyond the focus list, he contributed as a middle author to robust enumeration of cell subsets from tissue expression profiles with Aaron M. Newman, and to The Immune Landscape of Cancer consortium, both shaping widely used immune-profiling frameworks. His first-author